Zai Lab Ltd
HKEX:9688

Watchlist Manager
Zai Lab Ltd Logo
Zai Lab Ltd
HKEX:9688
Watchlist
Price: 19.76 HKD -3.61% Market Closed
Market Cap: 19.6B HKD
Have any thoughts about
Zai Lab Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Zai Lab Ltd stock under the Base Case scenario is 29.06 HKD. Compared to the current market price of 19.76 HKD, Zai Lab Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
29.06 HKD
Undervaluation 32%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Zai Lab Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Zai Lab Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Zai Lab Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Zai Lab Ltd

Provide an overview of the primary business activities
of Zai Lab Ltd.

What unique competitive advantages
does Zai Lab Ltd hold over its rivals?

What risks and challenges
does Zai Lab Ltd face in the near future?

Summarize the latest earnings call
of Zai Lab Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zai Lab Ltd.

Provide P/S
for Zai Lab Ltd.

Provide P/E
for Zai Lab Ltd.

Provide P/OCF
for Zai Lab Ltd.

Provide P/FCFE
for Zai Lab Ltd.

Provide P/B
for Zai Lab Ltd.

Provide EV/S
for Zai Lab Ltd.

Provide EV/GP
for Zai Lab Ltd.

Provide EV/EBITDA
for Zai Lab Ltd.

Provide EV/EBIT
for Zai Lab Ltd.

Provide EV/OCF
for Zai Lab Ltd.

Provide EV/FCFF
for Zai Lab Ltd.

Provide EV/IC
for Zai Lab Ltd.

Show me price targets
for Zai Lab Ltd made by professional analysts.

What are the Revenue projections
for Zai Lab Ltd?

How accurate were the past Revenue estimates
for Zai Lab Ltd?

What are the Net Income projections
for Zai Lab Ltd?

How accurate were the past Net Income estimates
for Zai Lab Ltd?

What are the EPS projections
for Zai Lab Ltd?

How accurate were the past EPS estimates
for Zai Lab Ltd?

What are the EBIT projections
for Zai Lab Ltd?

How accurate were the past EBIT estimates
for Zai Lab Ltd?

Compare the revenue forecasts
for Zai Lab Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zai Lab Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zai Lab Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zai Lab Ltd compared to its peers.

Compare the P/E ratios
of Zai Lab Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Zai Lab Ltd with its peers.

Analyze the financial leverage
of Zai Lab Ltd compared to its main competitors.

Show all profitability ratios
for Zai Lab Ltd.

Provide ROE
for Zai Lab Ltd.

Provide ROA
for Zai Lab Ltd.

Provide ROIC
for Zai Lab Ltd.

Provide ROCE
for Zai Lab Ltd.

Provide Gross Margin
for Zai Lab Ltd.

Provide Operating Margin
for Zai Lab Ltd.

Provide Net Margin
for Zai Lab Ltd.

Provide FCF Margin
for Zai Lab Ltd.

Show all solvency ratios
for Zai Lab Ltd.

Provide D/E Ratio
for Zai Lab Ltd.

Provide D/A Ratio
for Zai Lab Ltd.

Provide Interest Coverage Ratio
for Zai Lab Ltd.

Provide Altman Z-Score Ratio
for Zai Lab Ltd.

Provide Quick Ratio
for Zai Lab Ltd.

Provide Current Ratio
for Zai Lab Ltd.

Provide Cash Ratio
for Zai Lab Ltd.

What is the historical Revenue growth
over the last 5 years for Zai Lab Ltd?

What is the historical Net Income growth
over the last 5 years for Zai Lab Ltd?

What is the current Free Cash Flow
of Zai Lab Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zai Lab Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zai Lab Ltd

Current Assets 860.5m
Cash & Short-Term Investments 616.1m
Receivables 69.2m
Other Current Assets 175.2m
Non-Current Assets 124.8m
Long-Term Investments 3.2m
PP&E 63.6m
Intangibles 54.7m
Other Non-Current Assets 3.4m
Current Liabilities 286.3m
Accounts Payable 120.7m
Accrued Liabilities 46.3m
Short-Term Debt 113m
Other Current Liabilities 6.4m
Non-Current Liabilities 31.4m
Other Non-Current Liabilities 31.4m
Efficiency

Earnings Waterfall
Zai Lab Ltd

Revenue
355.7m USD
Cost of Revenue
-130.3m USD
Gross Profit
225.4m USD
Operating Expenses
-562.9m USD
Operating Income
-337.5m USD
Other Expenses
66.7m USD
Net Income
-270.8m USD

Free Cash Flow Analysis
Zai Lab Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the third quarter of 2024, Zai Lab's net product revenue surged 47% to $101.8 million, driven by a remarkable increase in VYVGART sales, which reached $27.3 million from $4.9 million year-over-year. The company expects to exceed $80 million in VYVGART sales by year-end, reinforcing its path to profitability by late 2025. Key advancements include promising data for ZL-1310 in small cell lung cancer, boasting a 74% objective response rate. With a cash position of $716 million and multiple product launches anticipated, Zai Lab aims to leverage its expanding pipeline to achieve over $1 billion in sales potential for VYVGART in China.

What is Earnings Call?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Zai Lab Ltd's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
36/100
Profitability
Score

Zai Lab Ltd's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Zai Lab Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
82/100
Solvency
Score

Zai Lab Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Zai Lab Ltd

Wall Street analysts forecast Zai Lab Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zai Lab Ltd is 37.29 HKD with a low forecast of 15.15 HKD and a high forecast of 69.05 HKD.

Lowest
Price Target
15.15 HKD
23% Downside
Average
Price Target
37.29 HKD
89% Upside
Highest
Price Target
69.05 HKD
249% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Zai Lab Ltd?

Click here to dive deeper.

Dividends

Zai Lab Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Zai Lab Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

Profile

Zai Lab Ltd Logo
Zai Lab Ltd

Country

China

Industry

Biotechnology

Market Cap

19.5B HKD

Dividend Yield

0%

Description

Zai Lab Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The firm is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The firm has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Contact

SHANGHAI
Shanghai
4560 Jinke Road, Bldg. 1, 4/F, Pudong
www.zailaboratory.com

IPO

2020-09-28

Employees

1 194

Officers

Founder, Chairperson & CEO
Dr. Ying Du Ph.D.
President & COO
Mr. Joshua L. Smiley
President and Head of Global Research & Development
Dr. Rafael G. Amado M.D.
Chief Financial Officer
Dr. Yajing Chen Ph.D.
Chief Scientific Officer
Dr. Peter Huang Ph.D.
Senior VP & Head of Investor Relations
Ms. Christine Chiou
Show More
Chief Legal Officer & Joint Corporate Secretary
Mr. Frazor Titus Edmondson III, J.D.
Executive VP & Head of Clinical Operations
Dr. Ning Xu M.D.
Chief Business Officer
Dr. Jonathan J. Wang MBA, Ph.D.
Chief Operating Officer of R&D
Dr. James Yan DABT, M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one Zai Lab Ltd stock?

The intrinsic value of one Zai Lab Ltd stock under the Base Case scenario is 29.06 HKD.

Is Zai Lab Ltd stock undervalued or overvalued?

Compared to the current market price of 19.76 HKD, Zai Lab Ltd is Undervalued by 32%.

Back to Top